Glycemic variability is associated with frequency of blood glucose testing and bolus: Post hoc analysis results from the ProAct study

Diabetes Technology and Therapeutics

Volumn 17, Issue 6, 2015, Pages 392-397

  Pfützner, Andreas ^a   Weissmann, Jörg ^b   Mougiakakou, Stavroula ^c   Daskalaki, Elena ^c   Weis, Norbert ^b   Ziegler, Ralph ^d  

^a PFÜTZNER Science and Health Institute   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d Clinic for Pediatric and Adolescent Diabetes   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART; INSULIN GLULISINE; INSULIN LISPRO; SHORT ACTING INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; DATA BASE; ENDOCRINE FUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; GLYCEMIC VARIABILITY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; J SCORE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POST HOC ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; TREATMENT DURATION; ANALYSIS; BLOOD; CLINICAL TRIAL; COMPLICATION; DEVICES; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION; INSULIN INFUSION; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84929236629     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0278     Document Type: Article

References (19)

1. Pickup JC: Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 2012;366:1616-1624.
2. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV: Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22:1779-1784.
3. Paul N, Kohno T, Klonoff DC: A review of the security of insulin pump infusion systems. J Diabetes Sci Technol 2011; 5:1557-1562.
4. Didangelos T, Iliadis F: Insulin pump therapy in adults. Diabetes Res Clin Pract 2011;93(Suppl 1):S109-S113.
5. Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group: Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-Nations Trial. Diabet Med 2006;23:141-147.
6. Pickup JC, Sutton AJ: Severe hypoglycemia and glycemic control in Type 1 patients: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008;25:765-774.
7. Ziegler R, Tubili C, Chico A, Guerci B, Lundberg E, Borchert M, Löffler A, Bloethner S, Weissmann J, Pfützner A: ProAct Study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems. Diabetes Technol Ther 2013;15:738-743.
8. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W: Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 2006;29:2433-2438.
9. Kovatchev BP, Clarke WL, Breton M, Brayman K, McCall A: Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical applications. Diabetes Technol Ther 2005;7:849-862.
10. Kovatchev BP, Straume M, Cox DJ, Gonder-Frederick LA, Clarke WL: Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in Type 1 and Type 2 diabetes using self-monitoring blood glucose data. Diabetes Technol Ther 2003;5:817-828.
11. Kovatchev BP, Straume M, Cox DJ, Farhi LS: Risk analysis of blood glucose data: a quantitative approach to optimizing the control of insulin dependent diabetes. J Theor Med 2001;3:1-10.
12. Hill NR, Hindmarsh PC, Stevens RJ, Stratton IM, Levy JC, Matthews DR: A method for assessing quality of control from glucose profiles. Diabet Med 2003;24:753-758.
13. Wojcicki J: "J"-index: A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res 1995;27:41-42.
14. Rodbard D: Interpretation of continuous glucose monitoring data: glycemic variability and quality of control. Diabetes Technol Ther 2009;11(Suppl 1):S-55-S-67.
15. Rodbard D: New and improved methods to characterize glycemic variability and quality of control. Diabetes Technol Ther 2009;11:551-565.
16. Schü tt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW; DPV Initiative: Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes 2006;114:384-388.
17. Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R; DPV-Wiss-Initiative: Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes 2011;12: 11-17.
18. Minder AE, Albrecht D, Schäfer J, Zulewski H: Frequency of blood glucose testing in well educated patients with diabetes mellitus type 1: how often is enough? Diabetes Res Clin Pract 2013;101:57-61.
19. Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB, Rodriguez H, Simmons JH, Hirsch IB; T1D Exchange Clinic Network: Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D Exchange Clinic Registry participants. Diabetes Care 2013;36:2009-2014.